- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作微信:1843439339 (QQ同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
原装正品Rybelsus (semaglutide)瑞倍适/瑞倍適,欧洲专业资质医药进出口公司,可B2B批量进出口贸易,航空速运确保原厂品质。
请联系E-mail / Whatsapp同账号:
ntccbio@163.com
工作微信:1843439339
Rybelsus (semaglutide) is an oral, once-daily prescription tablet designed for type 2 diabetes that often causes significant weight loss by slowing digestion and reducing appetite. While approved for blood sugar control, it is sometimes used off-label for weight management (BMI >30, or >27 with conditions). It requires strict, empty-stomach morning dosing.
Active Ingredient: Contains semaglutide, the same active ingredient as weight-loss injections Wegovy and Ozempic.
Mechanism: As a GLP-1 receptor agonist, it slows gastric emptying, making you feel fuller for longer, thus reducing calorie intake.
Effectiveness: Studies indicate that 50mg daily doses could result in up to 17.4% weight loss, although standard dosages (7mg/14mg) are lower.
How to Take: Take on an empty stomach immediately upon waking with a small sip of water (max 120ml). Wait at least 30 minutes before eating, drinking, or taking other medications.
Side Effects: Common side effects include nausea, vomiting, diarrhea, stomach pain, and constipation.
Dosage: Available in 3mg, 7mg, and 14mg doses, often starting lower to build tolerance.
您正在向 biovector.net 发送关于产品 Rybelsus (semaglutide)瑞倍适/瑞倍適 的询问
- 公告/新闻




